Embolization, Therapeutic
7
1
1
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
14.3%
1 terminated out of 7 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.
Artery Embolization vs Operation of Benign Prostate Hyperplasia
Caterpillar™ Arterial Embolization Device Post-Market Study
Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)
CATERPILLAR™ Arterial Embolization Device Study
Pelvic Varicose Veins Treated With Vascular Plugs Type Amplatzer: REPiVAC
Transarterial Coil Embolization of the Superior Rectal Arteries for Treatment of Stage II Hemorrhoids